ZIP14 contains two mutually exclusive exons, 4 A and 4B, and the ratio of exon 4 A/4B was significantly reduced in adenomas and cancers, which may be used as a tumor marker for identifying CRC and precancerous lesions. This evidence concerns the gene SLC39A14 and colorectal carcinoma.